Immunodiagnostic Systems Hldgs Plc enters a SARS-CoV-2 manufacturing agreement

Immunodiagnostic Systems Holdings Plc (LON: IDH) will provide contract manufacturing services to TBS (The Binding Site) related to their SARS-CoV-2 Antibody ELISA test.

  • The test had been introduced in Europe and other markets which accept the CE mark today and has also been submitted for rapid FDA approval.
  • The company’s facility in Boldon, UK, with the capacity to provide up to two million tests per month for TBS, will be producing the antibody coated ELISA microtiter plates for the test.
  • On 27 August 2020, at the time of writing, GMT 09:05 AM, IDH shares were trading at GBX 240.00, down by 5.00 points or 2.13% against the previous day closing price.

Comment


Disclaimer